TopFunds

Labcorp

NYSE: LH

Stock price

331.01 USD

(+0%) TODAY

Health Care ServicesMedical - Diagnostics & Research
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
4.3
7
12.2
8.6
8.4
15.9
24.4
14
4.8
8.8
10.5
9.2%
02Free cash flow per share
7.2
8.6
11
9
10.6
17.9
27.2
16.1
10
13
14.4
7.1%
03Dividends per share
-
-
-
-
-
-
-
1.9
2.7
2.9
2.9
-
04Dividends payout, %
-
-
-
-
-
-
-
15.3%
60.8%
32.6%
27.5%
-
PROFIT AND LOSS STATEMENT
05Revenue
$ 8,680
$ 9,642
$ 10,441
$ 11,333
$ 11,555
$ 13,979
$ 13,136
$ 11,864
$ 12,162
$ 13,009
$ 13,952
4.9%
06% Change
-
11.1%
8.3%
8.5%
2%
21%
(6)%
(9.7)%
2.5%
7%
7.3%
4.9%
07Cost of revenue
(5,777)
(6,461)
(6,977)
(8,157)
(8,302)
(9,026)
(8,144)
(8,155)
(8,797)
(9,385)
(10,219)
5.9%
08Gross profit
2,903
3,181
3,464
3,176
3,253
4,953
4,992
3,709
3,365
3,624
3,733
2.5%
09% Margin
33.5%
33%
33.2%
28%
28.2%
35.4%
38%
31.3%
27.7%
27.9%
26.8%
31.2% A
10Operating expenses
(1,787)
(1,810)
(2,029)
(1,803)
(1,868)
(2,507)
(1,944)
(2,272)
(2,639)
(2,538)
(2,216)
2.2%
11% of Revenue
(20.6)%
(18.8)%
(19.4)%
(15.9)%
(16.2)%
(17.9)%
(14.8)%
(19.2)%
(21.7)%
(19.5)%
(15.9)%
(18.2)% A
12Operating Income
1,003
1,312
1,364
1,326
1,330
2,445
3,049
1,437
725.6
1,087
1,516
4.2%
13Income tax expense
(294.1)
(372.3)
(139.1)
(384.4)
(280)
(662.1)
(690)
(233.9)
(188.5)
(212.4)
(229.8)
(2.4)%
14Net Income
436.9
732.1
1,268
883.7
823.8
1,556
2,377
1,279
418
746
876.5
7.2%
15% Margin
5%
7.6%
12.2%
7.8%
7.1%
11.1%
18.1%
10.8%
3.4%
5.7%
6.3%
8.7% A
16Shares Outstanding
100,600
104,300
103,900
102,600
98,600
98,000
97,500
91,600
87,600
84,400
83,800
(1.8)%
17EPS Basic
4.4
7.1
12.4
8.7
8.4
16
24.6
14
4.8
8.9
10.5
9.1%
18EPS Diluted
4.3
7
12.2
8.6
8.4
15.9
24.4
14
4.8
8.8
10.5
9.2%
19EBITDA
1,577
1,818
1,846
2,065
1,923
3,051
3,676
1,954
1,349
1,811
2,013
2.5%
% Margin
18.2%
18.9%
17.7%
18.2%
16.6%
21.8%
28%
16.5%
11.1%
13.9%
14.4%
17.8% A
20Net Interest Income (expense)
(274.9)
(219.1)
(235.1)
(244.2)
(240.7)
(207.4)
(211.8)
(179.8)
(199.6)
(208.3)
(208.9)
(2.7)%
21Net Debt / EBITDA
3.6
3
3.5
2.7
3.5
1.8
1.3
3
4
3.2
3.3
3 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
716.4
433.6
316.6
426.8
337.5
1,321
1,473
320.6
536.8
1,519
532.3
(2.9)%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
1,375
1,519
1,848
1,862
2,025
3,017
2,978
1,997
2,099
2,097
2,261
5.1%
25Other current assets
504.2
469.5
397.7
309
373.7
364.8
478.1
1,837
655.3
697.6
692.8
3.2%
26Inventory
191
205.2
227.6
237.3
244.7
423.2
401.4
470.6
474.6
493.2
534.7
10.8%
27Total Current Assets
2,663
2,479
2,683
2,835
2,981
5,125
5,331
4,625
3,765
4,807
4,021
4.2%
Non-Current Assets
28Net property, plant & equipment
1,747
1,719
1,749
1,785
2,612
2,730
2,815
2,794
2,912
3,045
3,082
5.8%
29Long-term investments
58.2
57.6
58.4
60.5
84.9
73.5
60.9
65.7
26.9
16.3
153.9
10.2%
30Other non-current assets
9,818
9,992
12,078
11,505
12,344
12,143
12,179
12,670
10,021
10,511
11,137
1.3%
31Total Non-Current Assets
11,623
11,768
13,885
13,350
15,040
14,946
15,055
15,529
12,960
13,573
14,372
2.2%
Total Assets
14,286
14,247
16,568
16,185
18,021
20,072
20,385
20,155
16,725
18,379
18,393
2.6%
LIABILITIES
Current Liabilities
32Accounts payable
497.4
508.4
573.9
634.6
632.3
638.9
621.3
852.2
827.5
875.8
840.8
5.4%
33Short-term debt
423.9
549.5
417.5
17.9
630.1
575.4
199
471.1
1,172
1,191
695.8
5.1%
34Other current liabilities
779.2
769.7
1,194
1,226
1,393
1,864
1,963
1,755
1,226
1,263
1,287
5.2%
35Total Current Liabilities
1,701
1,828
2,186
1,879
2,656
3,079
2,783
3,079
3,225
3,330
2,824
5.2%
Non-Current Liabilities
36Long-term debt
5,940
5,293
6,345
6,042
6,478
6,181
6,144
5,775
4,782
6,082
6,513
0.9%
37Other non-current liabilities
1,504
1,606
1,318
1,274
1,326
1,355
1,165
1,186
827.2
900.5
419.7
(12)%
38Total Non-Current Liabilities
7,444
6,898
7,662
7,316
7,804
7,536
7,309
6,961
5,609
6,982
6,933
(0.7)%
39Total Liabilities
9,145
8,726
9,848
9,195
10,459
10,614
10,091
10,040
8,835
10,313
9,756
0.7%
SHAREHOLDERS` EQUITY
40Common stock
12
12.1
12
11.7
9
9
8.5
8.1
7.7
7.6
7.5
(4.6)%
41Retained earnings / (deficit)
4,223
4,956
6,224
7,080
7,904
9,479
10,456
10,582
7,888
8,303
8,640
7.4%
42Accumulated other comprehensive income / (loss)
(221.1)
(581.1)
(335.7)
(463.1)
(372.4)
(161.9)
(192)
(493.2)
(59.3)
(261.6)
(27.6)
(18.8)%
43Noncontrolling interests
14.9
15.2
20.8
19.1
20.1
20.7
20.6
18.9
15.5
14.3
16.9
1.3%
44Total shareholders' equity
4,960
5,521
6,825
6,991
7,587
9,457
10,294
10,116
7,891
8,067
8,637
5.7%
45Total Liabilities and shareholders' Equity
14,286
14,247
16,568
16,185
18,021
20,072
20,385
20,155
16,725
18,379
18,393
2.6%
46Total Debt
6,364
5,850
6,762
6,060
7,108
6,756
6,343
6,246
5,954
7,273
7,204
1.3%
47Net Debt
5,648
5,416
6,446
5,633
6,770
5,436
4,870
5,926
5,417
5,754
6,672
1.7%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
436.9
732.1
1,268
883.7
823.8
1,556
2,377
1,279
418
746
876.5
7.2%
49Depreciation & amortization
457.8
499.2
533.2
552.1
577.2
624.7
577
537.2
577.3
643.5
681.1
4.1%
50Share-based compensation expense
102.1
109.6
109.7
91.6
107
111.7
132.9
116.8
128.7
116.7
125.8
2.1%
51Changes in working capital and other assets
(14.4)
(165)
(451.7)
(222)
(63.3)
(157.2)
22.4
22.8
203.7
79.6
(42.9)
11.5%
52Net cash flows from operating activities
982.4
1,176
1,459
1,305
1,445
2,135
3,110
1,956
1,328
1,586
1,641
5.3%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(255.8)
(278.9)
(315.4)
(379.8)
(400.2)
(381.7)
(460.4)
(481.9)
(453.6)
(489.9)
(434.5)
5.4%
54Purchases of investments / marketable securities
(11.7)
(12.5)
(36.2)
379.8
(27.5)
(40.1)
(27.8)
(17.4)
(29)
(55)
(192.4)
32.3%
55Proceeds from maturities of marketable securities
8
13.5
-
18.3
12.9
4.1
13.2
8.1
6.7
-
6.9
(1.5)%
56Other investing activities
(3,735)
(517.8)
(1,877)
188.4
(868.3)
(225.5)
(409.6)
(1,161)
(695.6)
(821.9)
(574)
(17.1)%
57Net cash flows from investing activities
(3,995)
(795.7)
(2,229)
206.7
(1,283)
(643.2)
(884.6)
(1,652)
(1,172)
(1,367)
(1,194)
(11.4)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
98.9
26.7
(264.5)
(630.9)
(385.3)
(134.5)
(1,617)
(1,100)
(1,040)
(250.1)
(395.7)
-
59Dividends paid, net
-
-
-
-
-
-
-
(195.2)
(254)
(243.1)
(240.7)
-
60Debt issuance (repayments), net
3,109
(666.8)
956.9
(695)
210.1
(412.2)
(375)
-
(300)
1,000
(775)
-
61Other financing activities
(23.7)
(9.7)
(60.5)
(64)
(77.5)
29.3
(74)
(27)
1,535
273.1
(45.6)
6.8%
62Net cash flows from financing activities
3,185
(649.8)
631.9
(1,390)
(252.7)
(517.4)
(2,066)
(1,322)
(59.3)
779.9
(1,457)
-
63Increase (decrease) in cash and cash equivalents
136.4
(282.8)
(116.9)
110.2
(89.3)
983.3
151.9
(1,043)
106.8
981.9
(986.4)
-
64Cash and equivalents, ending balance
716.4
433.6
316.7
426.8
337.5
1,321
1,473
430
536.8
1,519
532.3
(2.9)%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
726.6
897
1,144
925.6
1,045
1,754
2,649
1,474
874.1
1,096
1,206
5.2%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Labcorp (LH) financial statements and performance

Explore Labcorp (LH) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.